Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Biogen
Related studies linked through entity extraction aliases.
A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and Insomnia
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Evaluate Safety, Tolerability, and Distribution of a Microdose of Radiolabeled BIIB067 (99mTc-MAG3-BIIB067) Co-administered With BIIB067 (Tofersen) to Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Japanese Participants With Parkinson's Disease
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration
- Status
- COMPLETED
- Phase
- PHASE3
Wearable Assessments in the Clinic and Home in PD
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Participants With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
A Pharmacokinetic Study of Omaveloxolone in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study
- Status
- COMPLETED
- Phase
- N/A
TSPO PET as a Measure of Post-stroke Brain Inflammation: a Natural History Cohort
- Status
- COMPLETED
- Phase
- NA
A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities
- Status
- TERMINATED
- Phase
- PHASE2
802NP302 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1
Expanded Access to Omaveloxolone for Melanoma for Patients Previously Enrolled in 408-C-1401
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Safety and PK/PD of RTA 1701 in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis
- Status
- TERMINATED
- Phase
- PHASE2